Patent details

Basic Information

Publication number:

EP2589670

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP131525222

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Single nucleotide polymorphisms that predict HCV treatment outcomes

French Title of Invention:

POLYMORPHISME DE NUCLÉOTIDE UNIQUE POUR LA PRÉDICTION DU RÉSULTAT D'UN TRAITEMENT DU VHC

German Title of Invention:

EINZELNUCLEOTIDPOLIMORPHISMUS ZUR VORHERSAGE DES ERGEBNISSES EINER BEHANDLUNG BEI HCV

SPC Number:

Dates

Filing date:

11/04/2011

Grant date:

17/12/2014

EP Publication Date:

17/12/2014

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/05/2013

EP B1 Publication Date:

17/12/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/04/2015

Expiration date:

11/04/2031

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/04/2011

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

Lopatin Uri

Address:

United States (US)

2

Name:

Essioux Laurent

Address:

France (FR)

3

Name:

Thommes James

Address:

United States (US)

4

Name:

Germer Soren

Address:

United States (US)

5

Name:

Shulman Nancy

Address:

United States (US)

6

Name:

Chu Tom

Address:

United States (US)

Priority

Priority Number:

323502 P

Priority Date:

18/09/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C12Q 1/68;

Filing date	Document type	Number of pages